In vitro synergistic effect of AXL, FAK and ErbB receptors inhibitors for head and neck cancer.

Biol Direct · 2025 · PMC12225517 · PMID 40605022

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

The mode of interaction of the inhibitors in pairwise combination appeared to vary depending on the cell line and treatment duration, with the possible exception of the Y15 + AFA combination for which an overall trend toward additivity was observed.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.